Robert L. Henn

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

W. L. Gore & Associates, Inc. develops and manufactures products derived from fluoropolymers. It offers consumer products, cable and cable assemblies, electronic and electrochemical material, fabrics, fibers, filtration, medical, pharmaceutical processing, sealants and venting. The company was founded by Wilbert Lee Gore and Genevieve W. Gore on January 1, 1958 and is headquartered in Newark, DE.